Skip to content

Construction of PSEP based clinical prediction model to evaluation wound after BPH surgery

Construction of PSEP based clinical prediction model to evaluation wound after BPH surgery - Clinical Prediction Study of Aseptic Inflammation in Post-BPH Surgery Wounds Based on PSEP Detection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095335
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

cohort for model construction:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who meet the surgical indications for BPH and undergo transurethral thulium laser enucleation of the prostate. Possessing PSEP testing data: PSEP testing was conducted within 3 days prior to surgery and from 3 days to 1 week post-surgery. Possessing baseline IPSS scores, prostate volume (PV), and post-voided residual (PVR) data. Urine analysis, urine sediment, and urine culture test data were available at 1 week and from 1 to 3 months after surgery.

Exclusion criteria

Exclusion criteria: Patients who do not meet the surgical indications for BPH. Patients who lack clinical data, including PSEP, IPSS, PV, PVR, urine test, and urine culture, both before and after surgery. Patients with acute bacterial urinary tract infections both before and after surgery, as indicated by a positive urine test (WBC+), an excess of urinary sediment bacteria above the reference value's lower limit, or a positive urine culture result. Patients with systemic internal medicine diseases that have not been effectively controlled; and those with postoperative pathological reports indicating prostate cancer or other prostate diseases.

Design outcomes

Primary

MeasureTime frame
prostate exosomal protein,PSEP;prostate specific antigen;international prostate symptom score;quality of life;prostate volume;post-voided residual;urine flow rate;urinalysis;urine culture;

Countries

China

Contacts

Public ContactChenyi Jiang

Shanghai General Hospital

jcyjd1@163.com+86 152 1663 2291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026